Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Paul M Ridker
  • Jean G MacFadyen
  • Francisco A H Fonseca
  • Jacques Genest
  • Antonio M Gotto
  • John J P Kastelein
  • Wolfgang Koenig
  • Peter Libby
  • Alberto J Lorenzatti
  • Nordestgaard, Børge
  • James Shepherd
  • James T Willerson
  • Robert J Glynn
  • JUPITER Study Group
  • Paul M Ridker
  • Jean G MacFadyen
  • Francisco A H Fonseca
  • Jacques Genest
  • Antonio M Gotto
  • John J P Kastelein
  • Wolfgang Koenig
  • Peter Libby
  • Alberto J Lorenzatti
  • Nordestgaard, Børge
  • James Shepherd
  • James T Willerson
  • Robert J Glynn
  • JUPITER Study Group
Udgivelsesdato: 2009-Nov
OriginalsprogEngelsk
TidsskriftCirculation. Cardiovascular Quality and Outcomes
Vol/bind2
Udgave nummer6
Sider (fra-til)616-23
Antal sider8
ISSN1941-7713
DOI
StatusUdgivet - 1 nov. 2009

ID: 20596318